Fox Chase Cancer Center
Bladder
Fox Chase Updates in Bladder and Kidney Cancer 2019
Muscle-Invasive Bladder Cancer: Who Are the Ideal Candidates for Bladder Preservation and How Do Outcomes Compare to Radical Cystectomy / Therapy for Patients w/ Medically Inoperable Disease and How to Improve Tolerability of Treatment?
FEATURING
Mark A. Hallman
- 440 views
- November 22, 2019
- 4
Fox Chase Updates in Bladder and Kidney Cancer 2019
2019 1st Line Systemic Therapy for Metastatic Urothelial Carcinoma: Cisplatin as SoC, Pembro Mono as Alternative for Cis-Ineligible, Chemo +/- Atezolizumab vs. Atezolizumab Alone, Enfortumab Vedotin + Pembro, and Subsequent Therapies
FEATURING
Elizabeth R. Plimack
- 437 views
- November 22, 2019
- 4
